Siegfried Holding
Siegfried Holding AG, commonly referred to as Siegfried, is a prominent player in the pharmaceutical and chemical industry, headquartered in Switzerland (CH). Founded in 1873, the company has established a strong presence in Europe and North America, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Siegfried is renowned for its innovative solutions in contract development and manufacturing, catering to a diverse clientele in the pharmaceutical sector. The company’s commitment to quality and sustainability sets it apart, ensuring compliance with stringent regulatory standards. With a robust market position, Siegfried has achieved significant milestones, including strategic acquisitions that have expanded its capabilities and global reach. As a trusted partner in the pharmaceutical supply chain, Siegfried continues to drive advancements in drug development and production.
DitchCarbon Score
How does Siegfried Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Siegfried Holding's score of 74 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Siegfried Holding's reported carbon emissions
In 2023, Siegfried Holding, headquartered in Switzerland (CH), reported total carbon emissions of approximately 59,411,000 kg CO2e for Scope 1 and about 10,478,000 kg CO2e for Scope 2, with significant contributions from Scope 3 emissions, which totalled around 459,700,000 kg CO2e. The company has set ambitious climate commitments, aiming for a 50% reduction in its Scope 1 and 2 emissions by 2030, based on 2020 figures. This target is part of a broader strategy to achieve net-zero greenhouse gas emissions across its value chain by 2050. Siegfried's near-term targets include a 66.89% reduction in absolute Scope 1 and 2 emissions by 2033, alongside a commitment that 85% of its suppliers will have science-based targets by 2029. Additionally, the company plans to reduce Scope 3 emissions from specific categories, including fuel and energy-related activities and waste generated in operations, by 32.5% by 2033 from a 2022 baseline. Long-term, Siegfried aims for a 90% reduction in both Scope 1 and 2 emissions by 2050, as well as a similar reduction in Scope 3 emissions from various categories, including purchased goods and services. These initiatives reflect Siegfried's commitment to sustainability and its proactive approach to addressing climate change within the pharmaceutical and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 16,300,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siegfried Holding is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
